The global biobanks market, valued at USD 86.85 billion in 2025, is expected to reach approximately USD 191 billion by 2035, growing at a robust CAGR of 8.20%. This growth is driven by increasing demand for biobanking services in personalized medicine, drug discovery, and genomics research.

Biobanks Market Statical Scope

The biobanks are a place where essential human biological samples are stored, alongside it also help researchers with medical and general health-based data. The multiple benefit to the advance heathcare is aiming for a higher goal after witnessing data unification, relief, and smart purpose. The market contributes largely to the researchers in learning the genetic ecosystem and behavior. This further supports diabetes and cancer conditions with a precise solution.

The automation has taken the speed of robotic storage solutions, LIMS and artificial intelligence that spurs profit into the market. The popular outsourced services are generating massive revenue for the market. The rising demand for human tissue samples is fuelling more investment in healthcare, as the drug discovery and precision medicine growth is at its peak. Stem cell research is also attracting great revenue for the market.

Biobanks Market Share, By Region, 2025 (%)

• North America – The North America regional segment dominated the market by 40% of share due to the well-known automated green storage solution. Alongside the regional healthcare leaders are strongly attending the core beneficial areas of the market, while the virtual biobanking models are securing data.
• Europe – Europe leads by 25% of share in its elevating stem cell research space, demanding samples to continue with the solutions to the oncology field. The use of specimen management systems and cold storage technology is accelerating the growth of the regional market.
• Asia-Pacific – Asia Pacific covers 20% of profit due to the massive use of quality biological samples mainly for drug discovery, genomics and cancer research. The public and private sectors are an encouragement and a strength to the regional market as the investment promotes automated technologies and modern cold storage solutions.
• LAMEA – The LAMEA region acquires 15% of the share due to its popular first-ever robotic biobank in the UAE, and the Saudi Genome Program is a star of the regional market. The rising conditions like diabetes and cardiovascular disease are stimulating the growth of the market.

Biobanks Market Share, By Product and Services, 2025 (%)

• Services – The Services segment dominated the market by 60% of share, with the robust cell and gene therapies pipelines that provide endless specialty storage services. The virtual biobanking, automated storage systems and AI-powered sample tracking are a few of the modern services.
• Product – The product segment held 40% of the share with a promising high-throughput automation product for the sample retrieval, storage and handling. The rising demand for specialized biospecimens due to popular cell and gene therapy is accelerating growth in the segmental market.

Biobanks Market Share, By Biospecimen, 2025 (%)

• Human Tissues – The human tissues segment dominated the market by 37% of the share, as digitization, computerization and automated systems are ensuring best-in-class QC of sample processing. This partnership between the public and private sectors is strengthening the segmental market.
• Stem Cells – The segment covers 33% of the share as the expansion volume of the living biobanks is promoting the potency of the 3D functional models to develop proficiency in drug discovery, mainly featuring models of human tissues. This drives growth in the segmental market.
• Human Organs – The human organs segment rises by 30% with the fine cultivation of organoids due to researchers' efforts. This promotes commendable organoid models. The 3D cultures act as another source of profit and study for the segmental market.

Biobanks Market Share, By Biobank, 2025 (%)

• Physical/Real Biobanks – The physical/real biobanks segment dominated the market by 65% of share, as the reach of quality samples is essential to meet the clinical responsibility seeking the real biobanks for rising human conditions. The advanced physical biobanks hold the potential to balance biorepositories smoothly.
• Virtual Biobanks – The virtual biobanks held 35% of the share, with the additional tech-driven power of digitalization and AI. The smart partnership research gives more space to virtualization to allow laboratories to be a part of the vast studies.

Biobanks Market Share, By Application, 2025 (%)

• Therapeutics – The therapeutics segment dominated the market by 37% of share as the rise of COVID-19 elevated demand for samples for treatment and vaccines. Further, the alliances among biotech, biobanks and pharma drive more speed for drug discovery and translational research.
• Clinical Diagnostics – The clinical diagnostics segment leads by 40% of share with the boon of AI integration and the contribution of traditional academic biobanks. The utilization of biobanks with the endless number of chronic and cancer cases is leveraging growth in the segmental market.
• Drug Discovery and Clinical Research – The segment covers 23% of the share, as the expanding diagnostic biomarker validation process is strengthening the base of clinical studies. Following this, the clinical research space confirms more value in the market along with the specialised drug discovery biobanks.

Top Companies in the Biobanks Market

• Thermo Fisher Scientific Inc.
• Merck KGaA
• Qiagen
• Hamilton Company
• Tecan Trading AG
• Danaher Corporation
• Becton, Dickinson, and Company (BD)
• Biocision, LLC.
• Taylor-Wharton
• Charles River Laboratories
• Lonza
• Stemcell Technologies
• Biovault Family
• Promocell GmbH
• Precision Cellular Storage Ltd. (Virgin Health Bank)

Segments Covered in the Report

By Product & Services

• Product
• Services

By Biospecimen

• Human Tissues
• Human Organs
• Stem Cells

By Biobank

• Physical/Real Biobanks
• Virtual Biobanks

By Application

• Therapeutics
• Drug Discovery & Clinical Research
• Clinical Diagnostics

By Region

• North America
• Europe
• Asia-Pacific
• LAMEA